Japanese IT Stock News

TSE:6425
TSE:6425Leisure

Universal Entertainment (TSE:6425) Stock Rebounds To Profit As Deeper Losses Linger

Universal Entertainment stock closed at ¥691 ahead of the Q2 numbers, roughly flat over the past month and still carrying a double digit slide over the last quarter. The market has treated it like a troubled gaming stock that is merely cheap on sales. The headline today is that Q2 brought a sharp swing back into the black, with basic earnings per share of ¥19.19 on revenue of ¥48,132m, after a heavy loss in Q1 and a very large loss in late 2025. For anyone thinking beyond today’s tick chart,...
TSE:1802
TSE:1802Construction

Obayashi (TSE:1802) Stock Slides As One Off Gain Clouds Earnings Strength

Obayashi stock has been grinding lower for months, yet the latest results hand investors an awkward mirror. The share price sits at ¥3,030 after a three month slide of about 18%, while trailing earnings and margins look stronger on paper, helped by a very large one off gain of ¥56.2b. The real story today is a sentiment clash. The market still trades Obayashi on a P/E of 10.7x, below peers. At the same time, trailing net income and earnings per share paint a richer picture than the mood...
TSE:6254
TSE:6254Machinery

Nomura Micro Science (TSE:6254) Stock Faces Margin Squeeze After Softer Quarter

Nomura Micro Science stock enters this earnings season on a mixed footing. The shares closed at ¥4,225 on 7 August, with a solid 7 day gain but weaker 1 and 3 month performance. The market has been paying a rich P/E of about 45x for this semiconductor equipment specialist, while trailing net margin has eased to 6.8% from 10.1% a year earlier. The headline from this Q1 2027 print is margin pressure. Quarterly net income of ¥239 million on revenue of ¥9,202 million leaves investors asking how...
TSE:3774
TSE:3774Telecom

Internet Initiative Japan (TSE:3774) Stock Premium Meets Fresh Profit Pressure

Internet Initiative Japan entered this earnings release priced for quality growth, trading on a premium P/E and coming off a strong 90-day run. The stock closed at ¥3,632 on the day of the release, only modestly above recent levels, which suggests investors were cautious about paying up for perfection. The headline this quarter is profit pressure. Q1 2027 basic earnings per share of ¥24.79 came in well below the prior quarter, even as revenue held near ¥97.6b. For a stock already valued above...
TSE:7912
TSE:7912Commercial Services

Dai Nippon Printing (TSE:7912) Stock Premium Meets Shrinking Quarterly Profit

Dai Nippon Printing stock closed at ¥3,030 after Q1 results that left the share price treading water over the past month, even as the income statement told a sharper story. Basic earnings per share for the quarter landed at ¥54.78 and net income was ¥23,576m, which sits against a trailing P/E of 15.8x that is higher than the broader Japanese commercial services industry. For investors thinking beyond today’s move, the key issue is how much weight to put on that valuation premium given modest...
TSE:7733
TSE:7733Medical Equipment

Olympus (TSE:7733) Stock Top Line Strength Meets A Sharper Margin Reality

Olympus stock went into this earnings print already priced for perfection, trading on a trailing P/E of 25.9x and sitting above a discounted cash flow estimate of ¥1,837.15 at ¥1,906. That reflects a mood of confidence bordering on impatience. The headline from today is margin pressure. Trailing twelve month net profit margin is 7.5% compared with 11.6% a year earlier, weighed down by a one off loss of ¥35.9b. The market now has to decide whether that squeeze justifies such a rich multiple or...
TSE:9757
TSE:9757Professional Services

Funai Soken Holdings (TSE:9757) Stock Questions Profit Surge Built On One Off Gain

Funai Soken Holdings stock barely budged into this earnings print, with the 7 day and 30 day moves sitting close to flat. The calm share price masked a report built around one key story. Profitability looked rich on paper, with a trailing net margin of 23.7% and a 72.1% jump in earnings over the past year. Yet a ¥2.4b one off gain sits at the center of that strength. The real question for you is whether today’s muted reaction reflects clear eyed skepticism or a market that has stopped paying...
TSE:2702
TSE:2702Hospitality

McDonald’s Japan (TSE:2702) Stock Richly Valued Despite Firmer Margins

McDonald's Holdings Company Japan went into this earnings print with the stock roughly flat over the past week and modestly higher over the past quarter, which already signaled calm confidence rather than panic. The results then handed investors a clear headline. Profitability looks firmer than sentiment suggests, with trailing net margin sitting at 8.8% and basic earnings per share over the last twelve months at ¥276.55. The market now has to decide if a P/E of 29.1 on these numbers reflects...
TSE:9706
TSE:9706Infrastructure

Japan Airport Terminal (TSE:9706) Stock Gains Backing From Stronger Margins

Japan Airport Terminal stock came into this Q1 print with a solid run behind it and a ¥5,728 close that already priced in plenty of optimism about travel demand and duty free spending. The earnings headline is simple. Revenue held in the ¥74,126m range, while net income reached ¥8,418m and earnings per share landed at ¥90.69. For a company often treated as a pure traffic recovery story, the more interesting angle is margins. Trailing net profit margin sits around 10.6%, which keeps the focus...
TSE:2607
TSE:2607Food

Fuji Oil (TSE:2607) Stock Eyes Profit Rebound As Margins Stay Thin

Fuji Oil stock went into this earnings print quietly ahead of the pack, with a roughly flat month but a strong 3 month run behind it. The headline tonight is not revenue; it is profit. Basic earnings per share for Q1 2027 came in at ¥64.80 and net income reached ¥5,572 million, a sharp swing from the loss booked just one quarter ago. For a market fixated on whether Fuji Oil’s recent earnings rebound is real or a blip, this quarter lands as a psychological stress test. The price now has to...
TSE:1605
TSE:1605Oil and Gas

Inpex (TSE:1605) Stock Eyes LNG Cash Flow As Abadi Risk Builds

Inpex stock came into the earnings print looking tired, with the share price down about 3.5% over the past week and slightly lower over three months. The immediate temptation is to treat that drift as a verdict on the future. The headline from these results tells a different story. Inpex just posted record first half profit of ¥263.1b and reaffirmed a full year net profit target of ¥510b, backed by strong liquefied natural gas performance and heavy cash generation. Impressed by Inpex's record...
TSE:2815
TSE:2815Food

ARIAKE JAPAN (TSE:2815) Stock Faces Profit Dip Despite Steady Margins

ARIAKE JAPAN stock came into this earnings print priced for quality, trading on a trailing P/E of 18.3x while the broader Japan food sector sat lower. The market has been hesitant in recent months, with the share price roughly flat over 90 days and slightly down over the past week. The headline from this quarter is margin resilience rather than headline growth. Net profit margin over the last year sits at 13.6% compared with 13.3% the year before, and earnings per share for the trailing...
TSE:4966
TSE:4966Chemicals

C.UyemuraLtd (TSE:4966) Stock Cools As Profit Strength Meets Margin Drift

C.UyemuraLtd stock entered this Q1 2027 report on the back foot, with the share price down over the past week and month, yet the earnings print was anything but soft. Revenue reached ¥26,057m and basic earnings per share hit ¥280.40, both significant figures for a specialty chemicals producer where margins matter. The headline is simple: profit power held firm. Net income from ongoing operations landed at ¥4,491m and the trailing net margin stayed in the mid-teens. For a stock that has...
TSE:6460
TSE:6460Leisure

Sega Sammy (TSE:6460) Stock Rallies As Profit Returns But Losses Linger

Sega Sammy stock came into the Q1 print with a strong run behind it, up about 20% over the past three months and 15% over the past month, yet still trading well below one prominent fair value estimate. The headline today is simple: the group remains loss making over the last twelve months, even as Q1 delivered positive earnings per share and fresh revenue of ¥95,028m. Short term, traders are reacting to that tension between a healthier quarter and a still weak profit record. Long term...
TSE:1417
TSE:1417Construction

MIRAIT ONE (TSE:1417) Stock Slides As Margin Recovery Lifts Value Case

MIRAIT ONE stock has been grinding lower for months, with the shares down about 16% over 90 days, yet the latest earnings print tells a calmer story. Q1 2027 net income came in at ¥1,857 million on revenue of ¥130,033 million, which keeps the trailing 12 month earnings per share near ¥300 and supports a P/E of 11.6x. The real headline is margin. Net margin on a trailing basis sits at 4.3%, up from 2.6% a year ago. This is what longer term investors are likely to focus on rather than today’s...
TSE:1911
TSE:1911Consumer Durables

Sumitomo Forestry (TSE:1911) Stock Faces Margin Squeeze Despite Revenue Surge

Sumitomo Forestry stock went into this earnings print with a flat week and modest gains over the past quarter, then met a results day that put profitability under the microscope. The headline is not the top line. The story is the margin squeeze. Quarterly net income came in at ¥10,127m on revenue of ¥731,185m, which leaves the trailing net profit margin at 3.5% compared with 5.1% a year earlier. For a housing and wood products group that relies on tight execution, that kind of earnings...
TSE:7952
TSE:7952Leisure

Kawai (TSE:7952) Stock Confronts Thin Margins After Quarterly Loss

Kawai Musical Instruments Manufacturing came into this print with a premium story baked into the share price, trading on a 25.6x P/E and sitting at ¥3,560 after a strong three month run. The headline today is profit quality. Q1 delivered a small net loss of ¥116 million against a still positive trailing twelve month net income of ¥1,194 million, a profile that includes a sizeable one off gain and a modest 1.7% margin. For a stock priced above a discounted cash flow estimate of ¥1,823.83, that...
NSE:9357
NSE:9357Infrastructure

Meiko Trans (TSE:9357) Stock Margins Hold Firm As Valuation Questions Build

Meiko Trans entered this Q1 update with a reputation as a steady compounder in infrastructure, yet the stock has drifted only slightly over the past week despite a full year of earnings growth. The tension for you as an investor sits in one place: profitability is quietly doing the heavy lifting while the share price at ¥2,447 already trades above one discounted cash flow estimate. The headline in this quarter is margin and earnings resilience. Basic earnings per share of ¥54.05 in Q1 2027...
TSE:8354
TSE:8354Banks

Fukuoka Financial Group (TSE:8354) Stock Draws Support From Margin Led Profit Growth

The market came into Fukuoka Financial Group’s Q1 2027 print in a confident mood, with the stock up roughly 18% over three months and closing at ¥7,544 just as the results landed. The headline outcome is clear. Profit power is doing the heavy lifting. Basic earnings per share for the quarter stood at ¥151.92 and quarterly net income reached ¥28,708m. On a trailing basis earnings per share of ¥483.13 now sit against a P/E of 15.6x and a dividend yield of 2.78%. For a regional bank often viewed...
TSE:6465
TSE:6465Machinery

The Bull Case For Hoshizaki (TSE:6465) Could Change Following Stock Split And Capital Return Moves

Hoshizaki Corporation recently held a board meeting on August 6, 2026, to consider a stock split, related amendments to its Articles of Incorporation, potential treasury share acquisitions linked to the split, and the payment of interim dividends to shareholders. This combination of potential capital actions concentrates attention on how Hoshizaki balances shareholder returns, capital structure flexibility and longer-term corporate governance priorities. We will now examine how the proposed...
TSE:3003
TSE:3003Real Estate

Hulic (TSE:3003) Lifted Guidance And Dividend, Is The Stock Fairly Valued?

Why Hulic’s latest earnings, dividend and guidance matter for investors Hulic (TSE:3003) has moved into focus after its half year 2026 results, a higher interim dividend and fresh earnings guidance, giving investors several new data points to assess the real estate company. See our latest analysis for Hulic. Hulic’s latest earnings, higher interim dividend and fresh guidance have arrived after a period where the share price has been relatively range bound. The 1 year total shareholder return...
TSE:2914
TSE:2914Tobacco

What Japan Tobacco (TSE:2914)'s Dividend Hike and Upgraded 2026 Guidance Means For Shareholders

Japan Tobacco Inc. has already reported half-year 2026 results, with sales rising to ¥1,986.07 billion and net income to ¥431.83 billion, alongside sharply higher earnings per share. The company also raised its second-quarter dividend to ¥136.00 per share and upgraded full-year 2026 guidance, underlining management’s confidence in its earnings outlook. Next, we’ll examine how this upgraded full-year earnings guidance shapes Japan Tobacco’s investment narrative and prospects for future...
TSE:6954
TSE:6954Machinery

Fanuc (TSE:6954) Could Be 73% Above Fair Value After First Quarter Earnings

Why Fanuc’s Latest Quarterly Earnings Matter For Investors Fanuc (TSE:6954) just released first quarter results for the period to June 30, 2026, with sales of ¥231,035 million and net income of ¥50,981 million compared with the prior year. See our latest analysis for Fanuc. Fanuc’s latest earnings update comes as the share price sits at ¥6,535, with the stock down over the past quarter but supported by a strong 1 year total shareholder return of 52.97%, suggesting that momentum has cooled...
TSE:4502
TSE:4502Pharmaceuticals

Should FDA Approval of ORZEYFUL for Narcolepsy Type 1 Prompt Action From Takeda Pharmaceutical (TSE:4502) Investors?

On 5 August 2026, Takeda Pharmaceutical announced that the U.S. FDA approved ORZEYFUL (oveporexton), a first-in-class oral orexin receptor 2 agonist, for treating narcolepsy type 1 with cataplexy in adults, with commercial launch pending DEA controlled substance scheduling. This approval gives Takeda a differentiated entry into a rare disease market of an estimated 120,000 U.S. patients, addressing the underlying orexin deficiency rather than only individual narcolepsy symptoms. We will now...